Showing results (311-320 of 350) with videos related to
Sort By:
Pageof 35
Clinical Genitourinary Cancer|May 28, 2018
Is It Possible to Improve Prognostic Classification in Patients Affected by Metastatic Renal Cell Carcinoma With an Intermediate or Poor Prognosis?Roberto Iacovelli, Ugo De Giorgi, Luca Galli, et al.Journal of Experimental & Clinical Cancer Research : CR|April 19, 2020
Urinary expression of let-7c cluster as non-invasive tool to assess the risk of disease progression in patients with high grade non-muscle invasive bladder Cancer: a pilot studyManuela Spagnuolo, Manuela Costantini, Mariaconsiglia Ferriero, et al.Journal of Experimental & Clinical Cancer Research : CR|September 7, 2018
Renal cancer: new models and approach for personalizing therapySimona di Martino, Gabriele De Luca, Ludovica Grassi, et al.Breast (Edinburgh, Scotland)|June 20, 2017
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validationLuisa Carbognin, Isabella Sperduti, Alessandra Fabi, et al.Journal of Translational Medicine|May 18, 2018
Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world settingChiara Mandoj, Laura Pizzuti, Domenico Sergi, et al.Annals of Surgical Oncology|March 26, 2024
The Prognostic Role of the Number of Involved Structures in Thymic Epithelial Tumors: Results from the ESTS DatabaseMarco Chiappetta, Filippo Lococo, Carolina Sassorossi, et al.Current Urology|August 23, 2024
Proficiency score as a predictor of early trifecta achievement during the learning curve of robot-assisted radical prostatectomy for high-risk prostate cancer: Results of a multicentric seriesUmberto Anceschi, Rocco Simone Flammia, Antonio Tufano, et al.Breast Cancer Research and Treatment|September 20, 2014
Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER studyPatrizia Vici, Laura Pizzuti, Clara Natoli, et al.International Journal of Molecular Sciences|July 29, 2025
HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic CombinationsItalia Falcone, Elena Giontella, Stefano Giuliani, et al.Journal for Immunotherapy of Cancer|August 23, 2023
hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLCPaola Trono, Annalisa Tocci, Belinda Palermo, et al.Pageof 35